The Biospecimen Core will continue to provide high quality annotated specimens and expert pathology consultation to enhance the projects of Case GI SPORE investigators. This process will continue the longstanding, successful, collaborations between the members of the Core and the individual project investigators. During the course of these collaborations the Core has developed an extensive biospecimen archive derived from over 13,000 patients. Previously, the Core has supplied high quality annotated specimens leading to the discovery of 15-Prostaglandin Dehydrogenase as an important tumor suppressor gene in colon carcinogenesis ? the basis of Project 1; the African American colon cancer 15 gene-panel ? the basis of Project 2; methylated vimentin as a biomarker of Barrett's Esophagus ? the basis of Project 3; and the discovery of unique glutamine metabolism in PIK3CA mutated colon cancers ? the basis of Project 4. The Core also provided significant support to the SPORE's Career Enhancement and Pilot Projects Programs. The Core has an extensive archive of colon neoplasms from over 4,800 patients including 2,292 primary colon cancers of known pathologic stage and databased clinical follow-up as well as a substantial number of cancer metastases. Frozen material from 1053 of these cases is also banked with matched normal controls. The Core also has 350 esophageal cancers and Barrett's esophagus paraffin specimens as well as 134 frozen esophageal specimens. Many of these samples have undergone extensive molecular analysis ? enabling sophisticated translational studies. The Core works with the Case Comprehensive Cancer Center to make available to the SPORE a wide variety of techniques and technologies in a cost effective manner. The Core will organize all prospective GI biospecimen procurements and distribution to SPORE investigators as well as provide access to its existing tissue archive resource. The Core will support the projects of this application by identification of tissues of interest to investigators both from the Core archive and from prospective accrual. The Core will provide histopathological quality control for tissue sections, along with project specific morphology case reviews and will oversee and provide longitudinal follow-up of clinical outcomes linked to these tissues. The Core will also provide tissue microarray sections for tissue targets of interest, expertise in immunohistochemistry and in situ hybridization assessment and samples appropriate for specific studies. The primary objective is to provide a resource that contributes significantly to the translational goals and endpoints of the individual projects and to facilitate cooperation between other GI SPOREs.

Public Health Relevance

The Biospecimen Core supports the goals of the Case GI SPORE by provision of high quality biospecimens of multiple types to the SPORE investigators. The Biospecimen Core also provides multiple skills and services ? such as microdissection, immunohistochemistry and tissue microarrays and engages in ongoing consultation via regularly scheduled meetings to help ensure success of each SPORE project. The Core faculty have extensive experience in gastrointestinal translational research and have been integral to the scientific discoveries of the Case GI SPORE.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
United States
Zip Code
Yu, Ming; Maden, Sean K; Stachler, Matthew et al. (2018) Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis. Gut :
Berger, Nathan A (2018) New light on the pancreatic cyst conundrum. Transl Cancer Res 7:S545-S548
Sarvestani, Samaneh K; Signs, Steven A; Lefebvre, Veronique et al. (2018) Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids. Oncotarget 9:28717-28730
Berger, Nathan A (2018) Young Adult Cancer: Influence of the Obesity Pandemic. Obesity (Silver Spring) 26:641-650
Moinova, Helen R; LaFramboise, Thomas; Lutterbaugh, James D et al. (2018) Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus. Sci Transl Med 10:
Cooper, Gregory S; Markowitz, Sanford D; Chen, Zhengyi et al. (2018) Performance of multitarget stool DNA testing in African American patients. Cancer 124:3876-3880
Berger, Nathan A; Scacheri, Peter C (2018) Targeting Epigenetics to Prevent Obesity Promoted Cancers. Cancer Prev Res (Phila) 11:125-128
Cooper, Gregory S; Markowitz, Sanford D; Chen, Zhengyi et al. (2018) Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. Dig Dis Sci 63:1449-1453
Somasundaram, Saigopal; Forrest, Megan E; Moinova, Helen et al. (2018) The DNMT1-associated lincRNA DACOR1 reprograms genome-wide DNA methylation in colon cancer. Clin Epigenetics 10:127
Codipilly, Don Chamil; Chandar, Apoorva Krishna; Singh, Siddharth et al. (2018) The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Gastroenterology 154:2068-2086.e5

Showing the most recent 10 out of 141 publications